On-Demand access for ONS Bridge™ ends Oct. 30. Evaluations are also due by 11:59 pm EST Oct. 30.
Clinical practice guidelines assist in the management of side effects relating to cancer treatment and care.
Here's what ONS recommends when your workplace is affected.
ONS Interim Guidelines during the COVID-19 Pandemic
Get our fact sheet, manage PPE supplies, and learn about implications for patients with cancer.
ONS Information Regarding the Coronavirus (COVID-19)We are students, clinicians, scientists, educators, and mentors working together to transform the way the world cares for cancer.
In June 2020, the U.S. Food and Drug Administration granted accelerated approval to lurbinectedin (ZepzelcaTM) for adults with metastatic small cell lung cancer (SCLC) whose disease has progressed on or after platinum-based chemotherapy. The approval adds a second choice for patients who experience treatment-resistant SCLC progression, who previously had only topotecan as an option.
